Shared-risk (also called refund or money-back guarantee) IVF programs have become a major marketing tool for US fertility clinics. The pitch is appealing: pay a premium upfront for multiple IVF cycles, and if you don't take home a baby, you get most of your money back. It sounds like win-win — but the financial structure is more complex than the brochure suggests, and understanding how these programs actually work helps you evaluate whether they make sense for your situation — or whether Colombia's lower per-cycle costs make them irrelevant.
What Are Shared-Risk Programs?
A typical shared-risk program works like this: you pay a bundled fee — often $20,000–$40,000 — that covers multiple IVF cycles (typically 3–6 cycles including retrievals and transfers). If the program results in a live birth, you've paid the program fee and that's it. If it doesn't — after all included cycles are exhausted — you receive a partial refund, typically 50–100% of the program fee (minus medications, which are never refunded).
The clinic assumes the financial risk that treatment won't work. You pay a premium above the per-cycle cost in exchange for financial protection. The clinic prices the premium based on actuarial calculations — they accept patients likely enough to succeed that the premium covers the occasional refund.
The Financial Math
Let's compare the numbers for a patient who might need 2–3 cycles:
| Scenario | Pay-Per-Cycle (US) | Shared-Risk (US) | Pay-Per-Cycle (Colombia) |
|---|---|---|---|
| 1 cycle, success | $18,000–$25,000 | $25,000–$40,000 | $4,500–$7,000 |
| 2 cycles, success on #2 | $36,000–$50,000 | $25,000–$40,000 | $9,000–$14,000 |
| 3 cycles, success on #3 | $54,000–$75,000 | $25,000–$40,000 | $13,500–$21,000 |
| 3 cycles, no success | $54,000–$75,000 (no refund) | Refund of $12,500–$36,000 | $13,500–$21,000 (no refund) |
The clinic's business model works because they accept patients with favorable prognoses — young, good ovarian reserve, no severe male factor — who are statistically likely to succeed within 1–2 cycles. The premium from the many patients who succeed early funds the refunds for the few who don't. It's essentially insurance, and like all insurance, it's priced to be profitable for the insurer.
The Fine Print
Shared-risk programs come with significant restrictions that aren't always prominent in marketing materials:
Eligibility restrictions: Not everyone qualifies. Most programs have age limits (under 38–42), minimum AMH levels (usually above 1.0 ng/mL), BMI requirements, and exclusions for severe male factor, uterine abnormalities, or previous IVF failures. The patients most likely to need the financial protection of a refund program are often the ones excluded from it.
Medications excluded: The program fee typically doesn't include medications, which can add $3,000–$7,000 per cycle in the US. Even with a full refund of the program fee, you've lost the medication costs from every cycle.
Refund conditions: "No live birth" is defined specifically — usually as no take-home baby after all included cycles and transfers are complete. If you have frozen embryos remaining, the refund may not be available until those embryos are used or disposed of.
PGT-A and add-ons: Genetic testing, ICSI, and other add-ons may or may not be included — read carefully.
Transfer limits: Some programs limit the number of transfers (not just retrievals), potentially leaving unused embryos ineligible for the refund pathway.
Who Benefits (and Who Doesn't)
Shared-risk may benefit: Patients with a moderate prognosis (not great, not terrible) who want financial protection against the worst-case scenario. Patients who value peace of mind and are willing to pay a premium for it. Patients who would otherwise be unable to afford multiple cycles if the first one fails.
Shared-risk typically doesn't benefit: Patients with excellent prognosis (young, good reserve) — you're statistically likely to succeed on cycle 1 or 2 and overpaying for insurance you probably won't use. Patients who don't qualify (the ones who most need protection). Patients who could pursue multiple cycles in Colombia for less than the shared-risk program fee.
How Colombia Changes the Calculus
Colombia's IVF pricing fundamentally changes the shared-risk calculation. At $4,500–$7,000 per complete cycle (including ICSI and basic monitoring), a patient could pursue 3–4 full IVF cycles in Colombia for less than the cost of a single shared-risk program in the US. Even without a refund guarantee, the total financial exposure across multiple cycles in Colombia is lower than the premium for a US shared-risk program.
| Comparison | US Shared-Risk Program | 3 Cycles in Colombia |
|---|---|---|
| Total cost | $25,000–$40,000 + meds | $13,500–$21,000 + meds |
| If success on cycle 1 | Overpaid by $15,000–$30,000 | Paid $4,500–$7,000 |
| If no success after 3 | 50–100% refund (minus meds) | No refund, but $10,000–$20,000 less spent total |
| Eligibility | Restrictive | Open (clinic-assessed) |
| Medications cost | $9,000–$21,000 (3 cycles) | $2,400–$5,400 (3 cycles) |
For patients who qualify for US shared-risk programs (young, good prognosis), Colombia offers the same mathematical protection through lower per-cycle costs without the premium or the eligibility restrictions. For patients who don't qualify for US programs (older, lower reserve), Colombia provides affordable access to multiple attempts that shared-risk programs deny.
The bottom line: shared-risk programs solve a real problem — the financial anxiety of IVF uncertainty — but they solve it at a price that may not make sense when international alternatives offer comparable or better total-cost economics.
Explore Our Colombia Medical Network
Ready to Explore IVF in Colombia?
Connect with English-speaking fertility specialists in Medellín, Bogotá, and Cali. No pressure — just answers.
Start Your Fertility Consultation